Clin2
NCT07330531Possibly a fitNot yet recruiting

Checking how two drugs interact in healthy adults

Drug-drug Interaction Study

Treatments studied

This study checks how the body processes two medications when taken together: rifampin (an antibiotic) and anaprazole sodium (a stomach acid reducer). It is not a treatment trial — it is for healthy volunteers to see if these drugs interact in a way that could affect dosing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
24 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old.
  • You should be in good health with no major medical conditions.
  • Your weight must be at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women, with a healthy body mass index (BMI) between 19 and 28.
  • You must agree to use effective birth control and not donate sperm or eggs during the study and for 6 months after.
  • You must not have taken any prescription drugs in the last 4 weeks or over-the-counter drugs (including supplements) in the last 2 weeks.
  • You must not smoke more than 5 cigarettes per day and must be willing to stop using tobacco during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07357610Recruiting· Phase 1
Drug interaction study of SIM0270 in healthy adults

This trial tests how SIM0270 interacts with other drugs (itraconazole, rifampin, midazolam) in healthy Chinese adults. It helps doctors understand if SIM0270 is safe and how it works in the body.

Jinan, Shandong
NCT07535970Not yet recruiting· Phase 1
Drug interaction study in healthy adults

This study is testing whether a common antifungal drug (itraconazole) affects how the body processes a new experimental medicine (HS-10506). The goal is to see if the two drugs can be used together safely.

Jinan, Shandong
NCT07550621Not yet recruiting· Phase 1
Checking drug interactions of a new medicine in healthy adults

This study checks if a new oral drug, MDR-001, interacts safely with two common medicines (rifampin and itraconazole) when taken together. It's for healthy volunteers, and the results will help guide dosing for future patients.

Changchun, Jilin
NCT07862114Not yet recruiting· Phase 1
Testing drug interactions in healthy adults

This study checks if stomach acid medicine and another drug affect how the body handles a new investigational drug. It helps researchers understand dosing for future patients.

NCT07784608Not yet recruiting· Phase 1
Study of two experimental medicines together in healthy adults

This study checks if taking two experimental medicines together is safe and how they interact with each other in healthy volunteers. It tests whether the combination is well-tolerated and helps researchers understand how the body processes them.

Seoul, Seongbuk-gu
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu

Hear when a new Drug-drug Interaction Study trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.